Coya Therapeutics (COYA) Research & Development (2022 - 2026)

Coya Therapeutics (COYA) has 5 years of Research & Development data on file, last reported at $4.1 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 21.43% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at $15.6 million (up 12.02% YoY), and the FY2025 full-year result was $16.7 million, up 41.03% from the prior year.
• Research & Development fell to $4.1 million in Q1 2026, from $4.9 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $5.2 million in Q1 2025 to a low of $708032.0 in Q4 2022.
• A 5-year average of $2.5 million and a median of $1.9 million in 2024 frame the typical range for Research & Development.
• Across the five-year window, Research & Development retreated 26.21% in 2023 and surged 327.56% in 2024, its largest moves.
• Tracing COYA's Research & Development over 5 years: stood at $708032.0 in 2022, then soared by 127.34% to $1.6 million in 2023, then gained by 20.37% to $1.9 million in 2024, then surged by 155.0% to $4.9 million in 2025, then declined by 17.08% to $4.1 million in 2026.
• Business Quant data shows COYA's Research & Development at $4.1 million in Q1 2026, $4.9 million in Q4 2025, and $2.9 million in Q3 2025.